Table 1.
Characteristics of LACC patients treated with NAC followed by RH
| Characteristics | Number | % |
|---|---|---|
| Total patients | 38 | |
| Median age (range) | 49 (25–69) | |
| Performance status 0 | 38 | 100 |
| FIGO stage | ||
| 1B2 | 12 | 31.6 |
| 2B | 26 | 68.4 |
| Pathology | ||
| Squamous | 36 | 94.7 |
| Adenosquamous | 2 | 5.3 |
| Primary tumor size | ||
| >4 cm | 30 | 78.9 |
| ≦4 cm | 8 | 21.1 |
| Tumor response after NAC | ||
| CR | 5 | 13.2 |
| PR | 24 | 63.1 |
| SD | 8 | 21.1 |
| PD | 1 | 2.6 |
| Shirinkage rate | ||
| >50 % | 25 | 65.8 |
| ≦50 % | 13 | 34.2 |
| Lymph node metastasis | ||
| negative | 23 | 60.5 |
| positive pelvic | 15 | 39.5 |
| positive aortic | 4 | 10.5 |
| Recurrence | 10 | 26.3 |
CR Complete response, PR Partial response, SD Stable disease, PD Progressive disease